Tibolone: a review
- 16 November 1998
- Vol. 30 (3) , 295-305
- https://doi.org/10.1016/s0378-5122(98)00059-0
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- A 2-year study of lipid and lipoprotein changes in postmenopausal women with tibolone and estrogen-progestinPublished by Wolters Kluwer Health ,1999
- Effects of two doses of tibolone on trabecular and cortical bone loss in early postmenopausal women: A two-year randomized, placebo-controlled studyBone, 1996
- Short term blood pressure and metabolic effects of tibolone in postmenopausal women with non‐insulin dependent diabetesBJOG: An International Journal of Obstetrics and Gynaecology, 1996
- Summing up the Risk:Benefit EquationMenopause, 1996
- Predominance of Large LDL and Reduced HDL 2 Cholesterol in Normolipidemic Men With Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Effects of progestagens and Org OD14 in in vitro and in vivo tumor modelsThe Journal of Steroid Biochemistry and Molecular Biology, 1994
- The incidence of vaginal bleeding with tibolone treatmentBJOG: An International Journal of Obstetrics and Gynaecology, 1994
- Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroidAtherosclerosis, 1992
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis.BMJ, 1980